Current regulatory approaches for accessing potential COVID-19 therapies

被引：0

作者：

Vesa Halimi

Armond Daci

Simona Stojanovska

Irina Panovska-Stavridis

Milena Stevanovic

Venko Filipce

Aleksandra Grozdanova

机构：

[1] Faculty of Pharmacy,Department of Pharmacy, Faculty of Medicine

[2] University Ss. Cyril and Methodius,undefined

[3] University of Prishtina,undefined

[4] University Clinic of Hematology,undefined

[5] Medical Faculty,undefined

[6] University Ss. Cyril and Methodius,undefined

[7] University Clinic of Infection diseases and febrile conditions,undefined

[8] Medical Faculty,undefined

[9] University Ss. Cyril and Methodius,undefined

[10] University Clinic for Neurosurgery,undefined

[11] Medical Faculty,undefined

[12] University Ss. Cyril and Methodius,undefined

来源：

Journal of Pharmaceutical Policy and Practice | / 13卷

关键词：

COVID-19; Regulatory; EMA; FDA; Clinical studies; Compassionate use; Clinical practice; Off-label use; Emergency use;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients.

引用

共 50 条

[31] Immunomodulatory therapies for COVID-19
Mathur, Poonam
Kottilil, Shyamasundaran
FRONTIERS IN MEDICINE, 2022, 9
[32] Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities
Fan, Sijia
Wang, Hongling
Wu, Dean
Liu, Lu
ACTA PHARMACEUTICA, 2023, 73 (02) : 157 - 173
[33] Regulatory T cells: A potential weapon to combat COVID-19?
Liu, Yu
Qi, Guangying
Bellanti, Joseph A.
Moser, Rene
Ryffel, Bernhard
Zheng, Song Guo
MEDCOMM, 2020, 1 (02): : 157 - 164
[34] COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches
Laisuan, Wannada
FRONTIERS IN ALLERGY, 2021, 2
[35] Current Approaches to COVID-19 Drug Discovery and Safety Assessment
Williams, David E.
Kankanamge, Lakindu S. Pathira
CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (12) : 2183 - 2185
[36] Current practice and potential strategy in diagnosing COVID-19
Wan, D. -Y.
Luo, X. -Y.
Dong, W.
Zhang, Z. -W.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4548 - 4553
[37] COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines
Malcangi, Giuseppina
Inchingolo, Alessio Danilo
Inchingolo, Angelo Michele
Piras, Fabio
Settanni, Vito
Garofoli, Grazia
Palmieri, Giulia
Ceci, Sabino
Patano, Assunta
Mancini, Antonio
Vimercati, Luigi
Nemore, Damiano
Scardapane, Arnaldo
Rapone, Biagio
Semjonova, Alexandra
D'Oria, Maria Teresa
Macchia, Luigi
Bordea, Ioana Roxana
Migliore, Giovanni
Scarano, Antonio
Lorusso, Felice
Tartaglia, Gianluca Martino
Giovanniello, Delia
Nucci, Ludovica
Maggialetti, Nicola
Parisi, Antonio
Domenico, Marina Di
Brienza, Nicola
Tafuri, Silvio
Stefanizzi, Pasquale
Curatoli, Luigi
Corriero, Alberto
Contaldo, Maria
Inchingolo, Francesco
Dipalma, Gianna
CHILDREN-BASEL, 2022, 9 (02):
[38] COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management
Hossain, Md. Farhad
Hasana, Sharifa
Mamun, Abdullah Al
Uddin, Md. Sahab
Wahed, Mir Imam Ibne
Sarker, Sabarni
Behl, Tapan
Ullah, Irfan
Begum, Yesmin
Bulbul, Israt Jahan
Amran, Md. Shah
Rahman, Md. Habibur
Bin-Jumah, May N.
Alkahtani, Saad
Mousa, Shaker A.
Aleya, Lotfi
Abdel-Daim, Mohamed M.
FRONTIERS IN PHARMACOLOGY, 2020, 11
[39] Potential approaches to combat COVID-19: a mini-review
Sarwar, Zainab
Ahmad, Tahir
Kakar, Salik
MOLECULAR BIOLOGY REPORTS, 2020, 47 (12) : 9939 - 9949
[40] Potential approaches to combat COVID-19: a mini-review
Zainab Sarwar
Tahir Ahmad
Salik Kakar
Molecular Biology Reports, 2020, 47 : 9939 - 9949

← 1 2 3 4 5 →